<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87893">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01960881</url>
  </required_header>
  <id_info>
    <org_study_id>P14-096</org_study_id>
    <nct_id>NCT01960881</nct_id>
  </id_info>
  <brief_title>Evaluation of Diet and Exercise in Prostate Cancer Patients</brief_title>
  <acronym>CRONOS II</acronym>
  <official_title>Canadian Real Life Evaluation of Exercise and Diet in Patients Treated With Lupron® for the Management of Prostate Cancer:(CRONOS II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Canadian Urology Research Consortium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>JSS Medical Research Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>CMX Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AbbVie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Canadian Real Life Evaluation of the Effect of Diet and Exercise in Prostate Cancer Patients
      Managed with Lupron.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a study utilizing a prospective cohort design. Patients with Prostrate cancer (PCa)
      who are prescribed Lupron will be entered into the study cohort and will be followed for a
      maximum of 36 months with recommended assessments at 3, 6, 12, 18, 24, 30 and 36 months
      after Day 1. Treatment of the patients and follow up will be according to the physicians'
      judgment, regional regulations and the product monograph.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the patient quality of life (QoL) using the Medical Outcomes Study Short Form - 36 (SF-36)</measure>
    <time_frame>From Month 0 to Month 36</time_frame>
    <description>The SF-36 Health is a 36-item general health self-administered questionnaire consisting of 8 scales measuring Physical Function, Physical Role limitations, Vitality, General Health, Pain, Social Function, Emotional Role limitations, and Mental Health.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the University of California Los Angeles Prostate Cancer Index (UCLA-PI)</measure>
    <time_frame>From Month 0 to Month 36</time_frame>
    <description>A validated questionnaire designed to measure quality of life in patients with prostate cancer. It consists of 20 questions that assess urinary, sexual, bowel and hormonal function and impairment in patients with prostate cancer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the sexual function using the International Index of Erectile Function (IIEF-5)</measure>
    <time_frame>From Month 0 to Month 36</time_frame>
    <description>An abridged 5 item self-administered questionnaire assessing the presence and severity of erectile dysfunction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the proportion of patients with castrate levels of testosterone and normal levels of Prostatic Specific Antigen (PSA) at 36 months of treatments.</measure>
    <time_frame>From Month 0 to Month 36</time_frame>
    <description>The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood. A testosterone test checks the level of this male hormone (androgen) in the blood.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with Adverse Events</measure>
    <time_frame>From Month 0 to Month 36</time_frame>
    <description>Adverse events which lead to discontinuation of prescribed treatment under observation, will be coded according to the Medical Dictionary for Regulatory Activities (MeDRA) dictionary of terms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the patient's medical condition</measure>
    <time_frame>From Month 0 to Month 36</time_frame>
    <description>Any change in the patient's medical condition including new onset or worsening of medical conditions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the Doctor-Patient communication</measure>
    <time_frame>From Month 0 to Month 36</time_frame>
    <description>This will be ascertained with the Doctor-Patient Communication/Doctor's Questionnaire and the Doctor-Patient Communication/Patient's Questionnaire that are validated questionnaires developed by the College of Physicians of Quebec</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">860</enrollment>
  <condition>Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>Prostate Cancer Patients</arm_group_label>
    <description>Prostate Cancer Patients</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients will be enrolled from the offices of University or community
        urologists/radio-oncologists across Canada treating patients with PCa
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        i. Adult ≥ 18 years old

        ii. Has provided written informed consent allowing the use of their data for the study and
        providing permission for contact by the study personnel.

        iii. Diagnosed with PCa.

        iv. Prescribed Lupron as part of his treatment by his treating physician.

        Exclusion Criteria:

        i. Patient cannot or will not sign informed consent.

        ii. Presence of other condition that, in the opinion of the treating physician, prohibits
        the patient from participating in the study or obscures the assessment of the treatment of
        PCa.

        iii. Survival expectancy less than 2-3 years as per the treating physician judgment

        iv. No longer than 6 months of therapy if currently on Luteinizing hormone-releasing
        hormone (LHRH) agonist treatment.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christina Pelizon, MD</last_name>
    <role>Study Director</role>
    <affiliation>AbbVie Corporation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabelle Defoy, PhD</last_name>
    <phone>438-258-5150</phone>
    <email>isabelle.defoy@abbvie.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Viviane Jaar, MS</last_name>
    <phone>888-703-3006 ext 7047</phone>
    <email>viviane.jaar@abbvie.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Exdeo Clinical Research Inc /ID# 116040</name>
      <address>
        <city>Abbottsford</city>
        <zip>V2S 3N5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Barrie Urology Group /ID# 124295</name>
      <address>
        <city>Barrie</city>
        <zip>L4M 7G1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Male/Female Health and Research Centre /ID# 116042</name>
      <address>
        <city>Barrie</city>
        <zip>L4M 7G1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Edward F. Woods Medical Corporation /ID# 120695</name>
      <address>
        <city>Belleville</city>
        <zip>K8P 3Z9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jonathan Giddens Medicine /ID# 116023</name>
      <address>
        <city>Brampton</city>
        <zip>L6T 4S5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Brantford Urology Research /ID# 116026</name>
      <address>
        <city>Brantford</city>
        <zip>N8S 6T6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>G. Kenneth Jansz Medicine Professional Corporation /ID# 116024</name>
      <address>
        <city>Burlington</city>
        <zip>L7N 3V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Urology Resource Centre /ID# 116035</name>
      <address>
        <city>Burlington</city>
        <zip>L7S 1V2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique d'urologie /ID# 116019</name>
      <address>
        <city>Chicoutimi</city>
        <zip>G7H 4J1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Hopital de Gatineau, CSSS de Gatineau /ID# 131309</name>
      <address>
        <city>Gatineau</city>
        <zip>J8P 7H2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Charles-Le Moyne, CSSS Champlain- Charles-Le Moyne /ID# 134137</name>
      <address>
        <city>Greenfield Park</city>
        <zip>J4V 2H1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bureau du Dr. Carlos Marois /ID# 124296</name>
      <address>
        <city>Greenfield Park</city>
        <zip>J4V 2H2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Urology South Shore Research /ID# 116036</name>
      <address>
        <city>Greenfield Park</city>
        <zip>J4V 2H3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Center /ID# 118941</name>
      <address>
        <city>Halifax</city>
        <zip>B3H 3A7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Southern Interior Medical Research Inc. /ID# 116025</name>
      <address>
        <city>Kelowna</city>
        <zip>V1W 4V5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Queen's University /ID# 137983</name>
      <address>
        <city>Kingston</city>
        <zip>K7L 3J7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Urolaval /ID# 116037</name>
      <address>
        <city>Laval</city>
        <zip>H7G 2E6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital Cite-de-la-Sante /ID# 130951</name>
      <address>
        <city>Laval</city>
        <zip>H7M 3L9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>London Health Sciences Centre /ID# 118940</name>
      <address>
        <city>London</city>
        <zip>N6A 5W9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Giovanni DiCostanzo, Markham, CA /ID# 137272</name>
      <address>
        <city>Markham</city>
        <zip>L6B 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Miramichi Health Authority /ID# 124075</name>
      <address>
        <city>Miramichi</city>
        <zip>E1V 2N5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>CHUM - Notre-Dame Hospital /ID# 137271</name>
      <address>
        <city>Montreal</city>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHUM - Notre-Dame Hospital /ID# 137355</name>
      <address>
        <city>Montreal</city>
        <zip>H2L 4M1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>McGill University Health Centre /ID# 141503</name>
      <address>
        <city>Montreal</city>
        <zip>H2W 1S6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Jewish General Hospital, Sir Mortimer B. Davis /ID# 120416</name>
      <address>
        <city>Montreal</city>
        <zip>H3T 1E2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Mor Urology Inc /ID# 116027</name>
      <address>
        <city>Newmarket</city>
        <zip>L3X 1W1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Kamal Mattar, Niagara Falls, CA /ID# 137987</name>
      <address>
        <city>Niagara Falls</city>
        <zip>L2E 7H1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Stanley Flax Medical Professional Corporation /ID# 116022</name>
      <address>
        <city>North York</city>
        <zip>M2J 1V1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fe/Male Health Centers /ID# 116020</name>
      <address>
        <city>Oakville</city>
        <zip>L6H 3P1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital /ID# 132329</name>
      <address>
        <city>Ottawa</city>
        <zip>K1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. Sean Pierre Medicine /ID# 137986</name>
      <address>
        <city>Ottawa</city>
        <zip>K2H 9N6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kawartha Urology /ID# 116041</name>
      <address>
        <city>Peterborough</city>
        <zip>K9H 1T6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Medical Centre /ID# 128278</name>
      <address>
        <city>Peterborough</city>
        <zip>K9J 7B3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ultramed /ID# 116355</name>
      <address>
        <city>Pointe-Claire</city>
        <zip>H9R 4S3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Allan Blair Cancer Centre /ID# 137985</name>
      <address>
        <city>Regina</city>
        <zip>S4T 7T1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Richmond Hill Urology Practices Prostate Institute /ID# 137270</name>
      <address>
        <city>Richmond Hill</city>
        <zip>L4C 3X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CSSS Rimouski-Neigette /ID# 130612</name>
      <address>
        <city>Rimouski</city>
        <zip>G5L 5T1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Dr. Peter Erdeljan Medical Corporation Inc. /ID# 139641</name>
      <address>
        <city>Scarborough</city>
        <zip>M1P 2T7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Shawn Jay Soon Medicine Professional Corporation /ID# 116038</name>
      <address>
        <city>Scarborough</city>
        <zip>M1S 1T5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Urology and Male Fertility /ID# 116043</name>
      <address>
        <city>Scarborough</city>
        <zip>M1S 4V5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHUS Hopital Fleurimont /ID# 124275</name>
      <address>
        <city>Sherbrooke</city>
        <zip>J1H 5N4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Saint John Regional Hospital /ID# 141302</name>
      <address>
        <city>St. John</city>
        <zip>E2L 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Northern Urology Centre /ID# 141391</name>
      <address>
        <city>Sudbury</city>
        <zip>P3E 4T3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre /ID# 136597</name>
      <address>
        <city>Toronto</city>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Cancer Centre Radiation Oncologist /ID# 137984</name>
      <address>
        <city>Toronto</city>
        <zip>M5G 2M9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toronto Urology Clinical Study Group /ID# 116044</name>
      <address>
        <city>Toronto</city>
        <zip>M6A 3B5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bloor West Medical Centre /ID# 134134</name>
      <address>
        <city>Toronto</city>
        <zip>M6S 4W4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Toronto West Urology Group /ID# 116021</name>
      <address>
        <city>Toronto</city>
        <zip>M6S 4W4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre de Sante et de Services Sociaux de Trois Rivieres /ID# 131230</name>
      <address>
        <city>Trois-Rivieres</city>
        <zip>G8Z 3R9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Groupe de recherche en urologie de Mauricie /ID# 116356</name>
      <address>
        <city>Trois-Rivieres</city>
        <zip>G9A 3V7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Clinique des specialites chirurgicales de Val D'Or /ID# 116039</name>
      <address>
        <city>Val d'Or</city>
        <zip>J9P 1W3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Dr. J. Paul Whelan, Inc. /ID# 120415</name>
      <address>
        <city>Victoria</city>
        <zip>V8V 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>9120-1947 Quebec Inc. /ID# 129151</name>
      <address>
        <city>Westmount, Montreal</city>
        <zip>H3Z 2P9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cancer Care Manitoba /ID# 135976</name>
      <address>
        <city>Winnipeg</city>
        <zip>R3E 0V9</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://rxabbvie.com</url>
  </link>
  <verification_date>April 2017</verification_date>
  <lastchanged_date>April 5, 2017</lastchanged_date>
  <firstreceived_date>October 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prostate cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
